NCIt definition : The mesylate salt form of alflutinib, an orally available selective inhibitor of the
epidermal growth factor receptor (EGFR) mutant form T790M, with potential antineoplastic
activity. Upon administration, alflutinib specifically binds to and inhibits the tyrosine
kinase activity of EGFR T790M, a secondarily acquired resistance mutation. This prevents
EGFR T790M-mediated signaling and leads to cell death in EGFR T790M-expressing tumor
cells. EGFR, a receptor tyrosine kinase that is mutated in many tumor cell types,
plays a key role in tumor cell proliferation and tumor vascularization. Compared to
some other EGFR inhibitors, alflutinib may have therapeutic benefits in tumors with
T790M-mediated drug resistance.;
UNII : Q09ZKD19V0;
CAS number : 2130958-55-1; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 2130958-55-1
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;